Page last updated: 2024-10-25

ciprofloxacin and Female Genital Neoplasms

ciprofloxacin has been researched along with Female Genital Neoplasms in 3 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petru, E1
Singer, CF1
Polterauer, S1
Galid, A1
Schauer, C1
Klocker, J1
Seifert, M1
Reinthaller, A1
Benedicic, C1
Hubalek, M1
Hefler, L1
Marth, C1
Scholl-Firon, T1
Bogner, G1
Zeimet, AG1
Capett, MS1
Vollú-Silva, P1
Melchiades, VA1
Bokehi, LC1
Araújo, FM1
Martins, IS1
Neves, FPG1
Gonzalez, AGM1
Oswald, E1
de Paula, GR1
Teixeira, LA1
Markman, M1
Kennedy, A1
Webster, K1
Peterson, G1
Kulp, B1
Belinson, J1

Reviews

1 review available for ciprofloxacin and Female Genital Neoplasms

ArticleYear
Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
    Wiener medizinische Wochenschrift (1946), 2015, Volume: 165, Issue:19-20

    Topics: Cause of Death; Ciprofloxacin; Contraindications; Delayed-Action Preparations; Disease Progression;

2015

Other Studies

2 other studies available for ciprofloxacin and Female Genital Neoplasms

ArticleYear
Characterization of Ciprofloxacin-Resistant and Ciprofloxacin-Susceptible Uropathogenic Escherichia coli Obtained from Patients with Gynecological Cancer.
    Current microbiology, 2016, Volume: 73, Issue:5

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli Infections; Esche

2016
Experience with prophylactic oral ciprofloxacin in gynecological cancer patients developing severe chemotherapy-induced neutropenia.
    Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocol

2000